denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Program: Scientific Workshops
Session: Mitochondria and Metabolism - Blood Cancer Clinical Trials
Disclosures: Konopleva: Dark Blue Therapeutics: Membership on an entity's Board of Directors or advisory committees; Klondike Biopharma: Research Funding; Servier: Speakers Bureau; AbbVie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: clinical trials, Research Funding; Syndax: Membership on an entity's Board of Directors or advisory committees; MEI Pharma: Consultancy, Membership on an entity's Board of Directors or advisory committees; Auxenion GmbH: Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy, Other: clinical trials; Legend Biotech: Membership on an entity's Board of Directors or advisory committees; Sanofi Aventis: Consultancy; Novartis: Membership on an entity's Board of Directors or advisory committees; Intellisphere: Speakers Bureau; Curis: Consultancy; Adaptive: Consultancy; Vincerx: Consultancy; Menarini Group: Consultancy, Membership on an entity's Board of Directors or advisory committees.